Back to Archived Journals » Hypoxia » Volume 5

Original Research

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation

       
Total article views   HTML views PDF downloads Totals
8,634 Dovepress* 8,322+ 800 9,122
PubMed Central* 312 106 418
Totals 8,634 906 9,540
*Since 23 May 2017

View citations on PubMed Central and Google Scholar